Literature DB >> 3535932

Acquired immune haemolysis by anti A 1 antibody following bone marrow transplantation.

R J Haas, P Rieber, M Helmig, E Strobel, B H Belohradsky, M U Heim.   

Abstract

In ABO mismatched organ or bone marrow transplants recently some cases of acquired immune hemolysis have been reported. It was felt that these life threatening complications were due to immunosuppressive treatment with cyclosporin-A. A case of severe hemolysis following mismatched BMT is reported. Here no cyclosporin-A treatment was given since the bone marrow was T-cell deprived by an E-rosetting technique. Apparently T-cell purging can under these conditions become dangerous.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535932     DOI: 10.1007/BF00321102

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  10 in total

1.  Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.

Authors:  J Hows; K Beddow; E Gordon-Smith; D R Branch; W Spruce; I Sniecinski; R A Krance; L D Petz
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

2.  ABO haemolytic anaemia in transplanted patients.

Authors:  P C Bevan; M Seaman; B Tolliday; D G Chalmers
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

3.  Development of 'auto-anti-A1 antibodies' following alloimmunization in an A2 recipient.

Authors:  M Contreras; G R Hazlehurst; S E Armitage
Journal:  Br J Haematol       Date:  1983-12       Impact factor: 6.998

4.  ABO-incompatible marrow transplants.

Authors:  C D Buckner; R A Clift; J E Sanders; B Williams; M Gray; R Storb; E D Thomas
Journal:  Transplantation       Date:  1978-10       Impact factor: 4.939

5.  Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion.

Authors:  H G Braine; L L Sensenbrenner; S K Wright; P J Tutschka; R Saral; G W Santos
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

6.  Acquired hemolytic anemia due to "auto"-anti-A or "auto"-anti-B induced by group O homograft in renal transplant recipients.

Authors:  A K Mangal; G H Growe; M Sinclair; G F Stillwell; C E Reeve; S C Naiman
Journal:  Transfusion       Date:  1984 May-Jun       Impact factor: 3.157

7.  Expression of blood group A antigens in human bone marrow cells.

Authors:  K K Karhi; L C Andersson; P Vuopio; C G Gahmberg
Journal:  Blood       Date:  1981-01       Impact factor: 22.113

8.  Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch.

Authors:  P I Warkentin; J M Hilden; J H Kersey; N K Ramsay; J McCullough
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

9.  Inhibition of T-cell activity by cyclosporin A.

Authors:  L Andrus; K J Lafferty
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

10.  ABH antigens and bone marrow transplantation.

Authors:  C Hershko; R P Gale; W Ho; J Fitchen
Journal:  Br J Haematol       Date:  1980-01       Impact factor: 6.998

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.